Evidence map›Paper›PMID 41255619›Full record

ArticleFrontiers in medicine2025

Burden of chronic obstructive pulmonary disease in Ghana and globally from 1990 to 2021, with projections through 2050: a systematic analysis based on the Global Burden of Disease Study 2021.

Emmanuel Mensah, Min Liu, Lingling Pan, Wei Lu, Susheng Zhou, Liqin Zhang, Yusheng Cheng, Shuoshuo Wei, Lei Zha

Abstract read
In one paragraph

Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Emmanuel Mensah *Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College), Wuhu, Anhui, China.
Min Liu *Department of Graduate School of Bengbu Medical University, Bengbu Medical University, Bengbu, Anhui, China.
Lingling PanDepartment of Cardiology, The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College), Wuhu, Anhui, China.
Wei LuDepartment of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College), Wuhu, Anhui, China.
Susheng ZhouDepartment of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College), Wuhu, Anhui, China.
Liqin ZhangDepartment of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College), Wuhu, Anhui, China.
Yusheng ChengDepartment of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College), Wuhu, Anhui, China.
Shuoshuo WeiDepartment of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College), Wuhu, Anhui, China.
Lei ZhaDepartment of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College), Wuhu, Anhui, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To assess the burden of chronic obstructive pulmonary disease (COPD) in Ghana within a global context, analyze temporal trends and risk factor attribution from 1990 to 2021, and project the future burden through 2050. Study design: Secondary analysis of Global Burden of Disease (GBD) 2021 data, using statistical modeling to evaluate trends in COPD prevalence, incidence, mortality, disability-adjusted life years (DALYs), and attributable risk factors. Future projections were generated using Bayesian Age-Period-Cohort (BAPC) modeling. Data source: GBD 2021 study, providing standardized estimates for 369 diseases across 204 countries and territories. Main outcome measures: COPD-related deaths, prevalence, incidence, DALYs, age-standardized rates (ASRs), risk factor attribution, percentage change, age-specific death rates, and projections to 2050. Results: From 1990 to 2021, Ghana experienced a 157% increase in COPD deaths (from 693 to 1,782), compared to a 49% global increase. Ghana's age-standardized death rate (ASDR) declined by only 7%, far below the global reduction of 37%. COPD prevalence in Ghana tripled, rising from 0.1 to 0.3 million, while incidence increased by 215% and DALYs by 171%. Globally, DALYs rose by 40% over the same period. In Ghana, household air pollution from solid fuel use accounted for 40% of COPD deaths, followed by ambient air pollution (25%). Globally, particulate matter pollution (41%) and smoking (36%) were dominant. Projections show continued increases in prevalence and incidence, particularly among adults aged 40-64, with plateauing DALYs and declining ASDR by the 2040s. Mortality increases sharply after age 60, with higher burden among males. Cohort analysis reveals rising mortality risk among those born after 1960. Conclusion: Despite modest ASDR reductions, Ghana's absolute COPD burden is increasing, driven by preventable risk factors such as household air pollution. These findings highlight the need for targeted interventions, including clean cook-stove programs, improved air quality monitoring, and expanded access to spirometry and early screening. Such efforts are essential to reduce COPD-related morbidity and mortality and advance Sustainable Development Goal (SDG) 3.4.

Indexed as

Africaburden of diseasechronic obstructive pulmonary diseaseCOPDepidemiologyGhanaGlobal Burden of Diseaserisk factors

Identifiers

PMID41255619
PMCPMC12620206

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.